Cipher Capital’s Haemonetics HAE Stock Holding History

Cipher Capital’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-5,578	Closed	-$500K	–	559
2020 Q2	$500K	Sell	5,578 -4,801	-46%	-$485K	0.08%	314
2020 Q1	$1.03M	Buy	+10,379	New	+$1.13M	0.38%	72
2019 Q4	–	Sell	-1,883	Closed	-$238K	–	561
2019 Q3	$238K	Sell	1,883 -13,985	-88%	-$1.78M	0.02%	472
2019 Q2	$1.91M	Buy	+15,868	New	+$1.56M	0.16%	205
2019 Q1	–	Sell	-9,812	Closed	-$982K	–	594
2018 Q4	$982K	Sell	9,812 -5,298	-35%	-$557K	0.14%	227
2018 Q3	$1.73M	Buy	15,110 +11,865	+366%	+$1.23M	0.32%	95
2018 Q2	$291K	Buy	+3,245	New	+$274K	0.06%	358
2017 Q1	–	Sell	-33,230	Closed	-$1.34M	–	625
2016 Q4	$1.34M	Buy	33,230 +860	+3%	+$32.4K	0.09%	359
2016 Q3	$1.17M	Buy	32,370 +2,585	+9%	+$88.7K	0.07%	417
2016 Q2	$864K	Buy	+29,785	New	+$900K	0.06%	453
2014 Q2	–	Sell	-14,363	Closed	-$468K	–	443
2014 Q1	$468K	Buy	+14,363	New	+$549K	0.21%	191

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cipher Capital's HAE Position: Q3 2020 in Review

Cipher Capital sold out of Haemonetics (HAE) in Q3 2020, closing a stake of 5,578 shares — an estimated $500K sold.

Cipher Capital first reported a position in HAE in Q1 2014 and held it in 11 quarters. The position peaked at $1.91M in Q2 2019. 268 funds tracked by Wall St. Rank hold HAE as of Q3 2020.

Cipher Capital reported no remaining Haemonetics position as of Q3 2020 after selling out during the quarter.
Cipher Capital sold 5,578 Haemonetics shares in Q3 2020, an estimated $500K.
Cipher Capital first reported a position in Haemonetics in Q1 2014 and held it in 11 quarters.
Cipher Capital's Haemonetics position peaked at $1.91M in Q2 2019.
268 funds tracked by Wall St. Rank held Haemonetics as of Q3 2020.

Based on Cipher Capital's 13F filing for Q3 2020, filed 13 Nov 2020.